The human sideroflexin 5 (SFXN5) gene: sequence, expression analysis and exclusion as a candidate for PARK3.

[1]  A. Singleton,et al.  Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes , 2001, European Journal of Human Genetics.

[2]  Shawn K. Westaway,et al.  A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome , 2001, Nature Genetics.

[3]  C. Morris,et al.  Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease , 2001, Nature Genetics.

[4]  N. Hattori,et al.  An Unfolded Putative Transmembrane Polypeptide, which Can Lead to Endoplasmic Reticulum Stress, Is a Substrate of Parkin , 2001, Cell.

[5]  Nobutaka Hattori,et al.  Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease , 2001, Science.

[6]  N. Andrews,et al.  A mutation in a mitochondrial transmembrane protein is responsible for the pleiotropic hematological and skeletal phenotype of flexed-tail (f/f) mice. , 2001, Genes & development.

[7]  Z. Qian,et al.  Brain iron transport and neurodegeneration. , 2001, Trends in molecular medicine.

[8]  C. Tanner,et al.  Epidemiology of Parkinson's disease and akinetic syndromes , 2000, Current opinion in neurology.

[9]  Shinsei Minoshima,et al.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.

[10]  N. Wood,et al.  The genetics of Parkinson's disease. , 2000, Current opinion in genetics & development.

[11]  I. Ziv,et al.  Levodopa – an exotoxin or a therapeutic drug? , 2000, Journal of Neurology.

[12]  P. Lockhart,et al.  Identification of the copper chaperone SAH in Ovis aries: expression analysis and in vitro interaction of SAH with ATP7B. , 2000, Biochimica et biophysica acta.

[13]  N. Wood,et al.  The genetics of Parkinson's disease. , 1999, Current opinion in neurology.

[14]  M. Farrer,et al.  A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. , 1999, Human molecular genetics.

[15]  Georg Auburger,et al.  The ubiquitin pathway in Parkinson's disease , 1998, Nature.

[16]  Langston Jw.  Epidemiology versus genetics in parkinson's disease: Progress in resolving an age-old debate , 1998 .

[17]  David F. Clayton,et al.  The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease , 1998, Trends in Neurosciences.

[18]  B. Müller-Myhsok,et al.  A susceptibility locus for Parkinson's disease maps to chromosome 2p13 , 1998, Nature Genetics.

[19]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[20]  M. Polymeropoulos,et al.  Genetics of Parkinson's disease. , 1997, Human molecular genetics.

[21]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[22]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[23]  Z. Wszolek,et al.  Familial parkinsonism: Our experience and review. , 1995, Parkinsonism & related disorders.

[24]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[25]  Zbigniew K Wszolek,et al.  Hereditärer Morbus Parkinson: Bericht über drei Familien mit autosomal-dominantem Erbgang , 1993 .

[26]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[27]  Marvin B. Shapiro,et al.  RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. , 1987, Nucleic acids research.

[28]  M. Kozak.  Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. , 1984, Nucleic acids research.